Cargando…

Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism

BACKGROUND: Patients with end-stage renal disease have a higher risk of death from cardiovascular events, which can be mainly attributed to coronary artery calcification (CAC). Wnt signaling is involved in vascular development and may play a role in vascular calcification. This study aimed to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Tzung-Yo, Chen, Nai-Ching, Hsu, Chih-Yang, Huang, Chien-Wei, Lee, Po-Tsang, Chou, Kang-Ju, Fang, Hua-Chang, Chen, Chien-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721332/ https://www.ncbi.nlm.nih.gov/pubmed/31477034 http://dx.doi.org/10.1186/s12882-019-1543-3

Ejemplares similares

The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients
por: Chen, Nai-Ching, et al.
Publicado: (2017)

Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis
por: Chen, Chien-Liang, et al.
Publicado: (2019)

Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis
por: Weng, Cheng-Hao, et al.
Publicado: (2015)

Potential Role of Vegetarianism on Nutritional and Cardiovascular Status in Taiwanese Dialysis Patients: A Case-Control Study
por: Ou, Shih-Hsiang, et al.
Publicado: (2016)

Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification
por: Chen, Chien-Chih, et al.
Publicado: (2021)

The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients
por: Niu, Qingyu, et al.
Publicado: (2020)

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
por: Lee, Yueh-Ting, et al.
Publicado: (2013)

Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
por: Liu, En-Shao, et al.
Publicado: (2021)

Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020)

Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s
por: Ketteler, Markus, et al.
Publicado: (2022)

Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism
por: Sakai, Mariko, et al.
Publicado: (2020)

Coronary artery calcification score and common iliac artery calcification score in non‐dialysis CKD patients
por: Mizuiri, Sonoo, et al.
Publicado: (2018)

Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification
por: Hou, Yi-Chou, et al.
Publicado: (2019)

The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
por: Lu, Chien-Lin, et al.
Publicado: (2018)

Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients: a 5-year prospective cohort study
por: Chen, Hung-Chih, et al.
Publicado: (2018)

Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism
por: Oyama, Yuko, et al.
Publicado: (2010)

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2019)

Influence of sodium thiosulfate on coronary artery calcification of patients on dialysis: a meta-analysis
por: Huang, Chong, et al.
Publicado: (2023)

Myocardial Calcification due to Uncontrolled Hyperparathyroidism
por: Seo, Kyoung-Woo, et al.
Publicado: (2018)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
por: Xu, Zhou, et al.
Publicado: (2017)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Sun, Xiaoliang, et al.
Publicado: (2018)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
por: Abbas, Fizza, et al.
Publicado: (2019)

Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Zhang, Yi, et al.
Publicado: (2019)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2019)

Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
por: Shang, Da, et al.
Publicado: (2017)

Correction: Hou et al. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification. Nutrients 2019, 11(1):152
por: Hou, Yi-Chou, et al.
Publicado: (2019)

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism
por: Ma, Tsung-Liang, et al.
Publicado: (2015)

Hyperparathyroidism in a diabetic patient on dialysis
por: Hori, Michiko, et al.
Publicado: (2008)

Quality of Life After Surgery or Surveillance for Asymptomatic Primary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Trials
por: Cheng, Shih-Ping, et al.
Publicado: (2015)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
por: Nakayama, Kazunori, et al.
Publicado: (2013)

215 A Case of Calcific Uremic Arteriolopathy With Severe Secondary Hyperparathyroidism, How High Is High?
Publicado: (2022)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020)

Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients
por: Shang, Da, et al.
Publicado: (2015)

Can we predict who will develop postoperative hyperkalaemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism?
por: Song, Yu-Huan, et al.
Publicado: (2019)

Localization Strategy Prior to Radiofrequency Ablation for Primary and Secondary Hyperparathyroidism
por: Lee, Chih-Ying, et al.
Publicado: (2023)

The association between heart rhythm complexity and the severity of abdominal aorta calcification in peritoneal dialysis patients
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2018)

Aluminum overload in the reverse osmosis dialysis era: does it exist?
por: Chen, Mei-Yin, et al.
Publicado: (2022)

Risk analysis of dialysis-dependent patients who underwent coronary artery bypass grafting: Effects of dialysis modes on outcomes
por: Li, Han-Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lfp29kpm55k99eh9oeshaplvk0